Chinese Academy of Medical Sciences
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2014-12-09
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 200
- Registration Number
- NCT02313051
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China
Observational Study on the Patients With Rectal Cancer
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2016-01-18
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 3995
- Registration Number
- NCT02312284
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2014-11-26
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 71
- Registration Number
- NCT02301481
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT02296658
- Locations
- 🇨🇳
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2014-10-28
- Last Posted Date
- 2017-08-16
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT02276248
- Locations
- 🇨🇳
Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, Beijing, China
Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）
- Conditions
- Interventions
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2014-08-18
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT02218437
- Locations
- 🇨🇳
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer
- Conditions
- First Posted Date
- 2014-08-06
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Registration Number
- NCT02209441
Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer
- First Posted Date
- 2014-07-21
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 104
- Registration Number
- NCT02195141
- Locations
- 🇨🇳
Cancer Hospital, CAMS, Beijing, China
Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2014-10-21
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Registration Number
- NCT02136342
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma
- First Posted Date
- 2014-05-08
- Last Posted Date
- 2015-04-14
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 43
- Registration Number
- NCT02133612
- Locations
- 🇨🇳
Xiao Lv, Beijing, Beijing, China